Area of research
Molecular Biology · Pharmacology
Research interest
Research focused on Sulindac and Colorectal cancer, with related work in Function (biology), Wnt signaling pathway, Phosphodiesterase. Notable publications include 'Sulindac Selectively Inhibits Colon Tumor Cell Growth by Activating the cGMP/PKG Pathway to Suppress Wnt/β-Catenin Signaling', 'A Novel Sulindac Derivative that Potently Suppresses Colon Tumor Cell Growth by Inhibiting cGMP Phosphodiesterase and β-Catenin Transcriptional Activity', and 'New NSAID Targets and Derivatives for Colorectal Cancer Chemoprevention'.
Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in Rats
Cyclic GMP signaling during human lactation and breast cancer: Implications for breast cancer prevention
Using the Cell Engineer/Detective Approach to Explore Cell Structure and Function
Sulindac Selectively Inhibits Colon Tumor Cell Growth by Activating the cGMP/PKG Pathway to Suppress Wnt/β-Catenin Signaling
A Novel Sulindac Derivative that Potently Suppresses Colon Tumor Cell Growth by Inhibiting cGMP Phosphodiesterase and β-Catenin Transcriptional Activity
New NSAID Targets and Derivatives for Colorectal Cancer Chemoprevention